German Stocks: Continental champs
16 No. of Symbols
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.10 USD
−2.64 B USD
48.25 B USD
982.35 M
About Bayer AG
Sector
Industry
CEO
William N. Anderson
Website
Headquarters
Leverkusen
Founded
1952
ISIN
DE000BAY0017
FIGI
BBG000BX92S0
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
BAYZ4646646
Bayer US Finance II LLC 4.625% 25-JUN-2038Yield to maturity
—
Maturity date
Jun 25, 2038
BAYZ4804053
Bayer US Finance II LLC 3.6% 15-JUL-2042Yield to maturity
—
Maturity date
Jul 15, 2042
BAYZ4140709
Monsanto Company 4.2% 15-JUL-2034Yield to maturity
—
Maturity date
Jul 15, 2034
BAYZ4810288
Bayer Corporation 6.65% 15-FEB-2028Yield to maturity
—
Maturity date
Feb 15, 2028
BAYZ3949796
Conceptus, Inc. 5.0% 15-DEC-2031Yield to maturity
—
Maturity date
Dec 15, 2031
BAYZ4660477
Bayer US Finance II LLC 4.2% 15-JUL-2034Yield to maturity
—
Maturity date
Jul 15, 2034
BAYZ4646644
Bayer US Finance II LLC 4.25% 15-DEC-2025Yield to maturity
—
Maturity date
Dec 15, 2025
BAYZ4140706
Monsanto Company 4.7% 15-JUL-2064Yield to maturity
—
Maturity date
Jul 15, 2064
MON.GD
Monsanto Finance Canada Co. 5.5% 30-JUL-2035Yield to maturity
—
Maturity date
Jul 30, 2035
BAYZ4841297
Bayer US Finance II LLC 5.5% 30-JUL-2035Yield to maturity
—
Maturity date
Jul 30, 2035
BAYZ4662675
Bayer US Finance II LLC 4.4% 15-JUL-2044Yield to maturity
—
Maturity date
Jul 15, 2044
See all BAYZF bonds
Curated watchlists where BAYZF is featured.
Frequently Asked Questions
The current price of BAYZF is 33.11 USD — it has increased by 2.92% in the past 24 hours. Watch Bayer A.G. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Bayer A.G. stocks are traded under the ticker BAYZF.
BAYZF stock has fallen by −0.03% compared to the previous week, the month change is a 11.30% rise, over the last year Bayer A.G. has showed a 2.79% increase.
We've gathered analysts' opinions on Bayer A.G. future price: according to them, BAYZF price has a max estimate of 40.98 USD and a min estimate of 26.93 USD. Watch BAYZF chart and read a more detailed Bayer A.G. stock forecast: see what analysts think of Bayer A.G. and suggest that you do with its stocks.
BAYZF reached its all-time high on Dec 28, 2007 with the price of 920.00 USD, and its all-time low was 19.50 USD and was reached on Dec 19, 2024. View more price dynamics on BAYZF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BAYZF stock is 1.15% volatile and has beta coefficient of 0.80. Track Bayer A.G. stock price on the chart and check out the list of the most volatile stocks — is Bayer A.G. there?
Today Bayer A.G. has the market capitalization of 32.40 B, it has decreased by −0.11% over the last week.
Yes, you can track Bayer A.G. financials in yearly and quarterly reports right on TradingView.
Bayer A.G. is going to release the next earnings report on Nov 11, 2025. Keep track of upcoming events with our Earnings Calendar.
BAYZF earnings for the last quarter are 1.45 USD per share, whereas the estimation was 1.06 USD resulting in a 37.03% surprise. The estimated earnings for the next quarter are 0.44 USD per share. See more details about Bayer A.G. earnings.
Bayer A.G. revenue for the last quarter amounts to 12.65 B USD, despite the estimated figure of 12.69 B USD. In the next quarter, revenue is expected to reach 11.43 B USD.
BAYZF net income for the last quarter is −234.42 M USD, while the quarter before that showed 1.41 B USD of net income which accounts for −116.68% change. Track more Bayer A.G. financial stats to get the full picture.
Yes, BAYZF dividends are paid annually. The last dividend per share was 0.13 USD. As of today, Dividend Yield (TTM)% is 0.39%. Tracking Bayer A.G. dividends might help you take more informed decisions.
As of Sep 8, 2025, the company has 92.81 K employees. See our rating of the largest employees — is Bayer A.G. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bayer A.G. EBITDA is 9.70 B USD, and current EBITDA margin is 18.30%. See more stats in Bayer A.G. financial statements.
Like other stocks, BAYZF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bayer A.G. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bayer A.G. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bayer A.G. stock shows the neutral signal. See more of Bayer A.G. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.